Edencolors Officially Launches “inBo” in Thailand with The Epic Reveal: inBo Launch Seminar
Edencolors Officially Launches “inBo” in Thailand with The Epic Reveal: inBo Launch Seminar
Edencolors recently launched inBo in Thailand for the first time through an academic seminar titled THE EPIC REVEAL: inBo Launch. This event gathered numerous dermatologists and aesthetic practitioners to share knowledge and insights on the evolving direction of Botulinum Toxin in Thailand’s beauty market.
On June 9, 2025, Edencolors (Thailand) Co., Ltd. officially launched inBo, a Swedish-Korean developed Botulinum Toxin product in Thailand. The event, held at the Regency Ballroom on the 5th floor of the Hyatt Regency Bangkok Sukhumvit, saw immense interest from dermatologists and clinic owners.
inBo – A New Standard of Botulinum Toxin
inBo is a Botulinum Toxin product developed through advanced production technology in Korea, utilizing a strain originally sourced from Sweden—CCUG 7968. The development aims to ensure high purity and transparency in traceability of the bacterial strain, which is vital for medical and aesthetic applications.
inBo: Innovation That Begins with the Strain
The seminar opened with welcome remarks from Dr. Chutima Atsaniradakorn, CEO of Edencolors (Thailand), and Mr. Victor Lee, CEO of Inibio, Korea, warmly welcomed all attending physicians. They shared their vision and approach for introducing inBo to the Thai market, highlighting its strengths in production technology and its emphasis on natural-looking results – a core value Edencolors upholds across all its products.
One of the key highlights that intrigued many physicians was that inBo is developed using the Clostridium botulinum strain CCUG 7968, officially stored at the Culture Collection University of Gothenburg (CCUG) in Sweden. This international science center is known for its rigorous strain verification and microbiological safety standards. This marks the first time this strain has been utilized for aesthetic and medical purposes.
inBo Inspired by Real Experiences
A particularly well-received moment of the event was the introduction of the Face of inBo – Mint Chalida Vijitvongthong, a well-known actress and skincare enthusiast. She shared her personal experience as a user and brand ambassador under the topic:
“Becoming the Face of a Brand I Truly Believe In.”
Mint Chalida expressed her confidence in the brand:
"What gave me the courage to choose inBo wasn’t just the visible results, but the brand's meticulous care from its very origin – from the origin of the strain to the scientific team behind it, and Edencolors’ vision of delivering natural-looking, safe, and standardized products, it made me feel truly secure."
Edencolors believes that having a brand ambassador who genuinely understands and communicates the product's value will help inBo resonate with its target consumers even more effectively.
Dermatologists Share Insights and Experiences
The event also featured insightful academic lectures and discussions on crucial topics, including medical ethics, advertising regulations in aesthetics, and complication management when using Botulinum Toxin. Several esteemed dermatologists honored the event by sharing their expertise:
- Prof. Rungsima Wanitphakdeedecha, M.D., Ph.D. presented on "Toxin Talk: The Do’s & Don’ts for inbo." offering practical advice and precautions for Botulinum Toxin use from the perspectives of both medical practitioners and aesthetic clinics, emphasizing academic accuracy and medical ethics.
- Prof. Vasanop Vachiramon, M.D. provided in-depth insights into raw materials and the variability of different substances in "Understanding the Variability of Botulinum Toxin."
- Asst.Prof. Mart Maiprasert, M.D. lectured on "Boundaries in Medical Advertising: Ethics & Laws," focusing on helping doctors and aesthetic clinics understand the legal framework related to communicating about products like Botulinum Toxin to avoid exaggerated claims.
- Asst. Prof. Dr. Thanya Techapichetvanich, M.D. presented "Injecting with Intention," delving into anatomical perspectives for safe and precise Botulinum Toxin injections.
- Lattaphon Malaithong, M.D. shared knowledge on potential complications from Botulinum Toxin use, covering mechanisms of occurrence, diagnosis, prevention, and appropriate management in "Complications of Botulinum Toxin."
- Chatchai Choosaeng, M.D. explained the technology behind inBo under the topic "Purity, Precision, Performance."
- Kriangkrai Aowudompan, M.D. explained the technology behind TESS PREDERM™ thread lift products, an innovation that enhances deep skin rejuvenation, suitable for use in conjunction with aesthetic procedures like Botulinum Toxin or dermal fillers for smoother and more natural results.
More Than Just a Product Launch - A New Standard in Aesthetics
The development of inBo focuses on the purity of the substance, stable proteins, and the absence of unnecessary complexing proteins, which can potentially reduce the risk of long-term "Botulinum toxin resistance."
For Edencolors, the launch of inBo is not merely about introducing a new product to the market. It also signifies a commitment to elevating Thailand's aesthetic industry to a transparent, verifiable standard, prioritizing consumer safety above all else.
Looking Ahead: Innovation with Responsibility
With the collaboration between Edencolors (Thailand) and Inibio, Korea, inBo is expected to be a new choice for both physicians and consumers seeking a Botulinum Toxin backed by research, and delivers natural-looking results in line with modern aesthetic preferences to enhance their self-confidence.
Edencolors also emphasizes the importance of choosing certified products and undergoing procedures only at licensed and traceable clinics. Edencolors is the sole importer and distributor of inBo in Thailand, and consumers are encouraged to verify product authenticity before receiving treatments to ensure their safety.
For more information about inBo and other Edencolors products, please visit www.edencolors.co.th.
Edencolors Officially Launches “inBo” in Thailand with The Epic Reveal: inBo Launch Seminar
Edencolors Officially Launches “inBo” in Thailand with The Epic Reveal: inBo Launch Seminar
Edencolors recently launched inBo in Thailand for the first time through an academic seminar titled THE EPIC REVEAL: inBo Launch. This event gathered numerous dermatologists and aesthetic practitioners to share knowledge and insights on the evolving direction of Botulinum Toxin in Thailand’s beauty market.
On June 9, 2025, Edencolors (Thailand) Co., Ltd. officially launched inBo, a Swedish-Korean developed Botulinum Toxin product in Thailand. The event, held at the Regency Ballroom on the 5th floor of the Hyatt Regency Bangkok Sukhumvit, saw immense interest from dermatologists and clinic owners.
inBo – A New Standard of Botulinum Toxin
inBo is a Botulinum Toxin product developed through advanced production technology in Korea, utilizing a strain originally sourced from Sweden—CCUG 7968. The development aims to ensure high purity and transparency in traceability of the bacterial strain, which is vital for medical and aesthetic applications.
inBo: Innovation That Begins with the Strain
The seminar opened with welcome remarks from Dr. Chutima Atsaniradakorn, CEO of Edencolors (Thailand), and Mr. Victor Lee, CEO of Inibio, Korea, warmly welcomed all attending physicians. They shared their vision and approach for introducing inBo to the Thai market, highlighting its strengths in production technology and its emphasis on natural-looking results – a core value Edencolors upholds across all its products.
One of the key highlights that intrigued many physicians was that inBo is developed using the Clostridium botulinum strain CCUG 7968, officially stored at the Culture Collection University of Gothenburg (CCUG) in Sweden. This international science center is known for its rigorous strain verification and microbiological safety standards. This marks the first time this strain has been utilized for aesthetic and medical purposes.
inBo Inspired by Real Experiences
A particularly well-received moment of the event was the introduction of the Face of inBo – Mint Chalida Vijitvongthong, a well-known actress and skincare enthusiast. She shared her personal experience as a user and brand ambassador under the topic:
“Becoming the Face of a Brand I Truly Believe In.”
Mint Chalida expressed her confidence in the brand:
"What gave me the courage to choose inBo wasn’t just the visible results, but the brand's meticulous care from its very origin – from the origin of the strain to the scientific team behind it, and Edencolors’ vision of delivering natural-looking, safe, and standardized products, it made me feel truly secure."
Edencolors believes that having a brand ambassador who genuinely understands and communicates the product's value will help inBo resonate with its target consumers even more effectively.
Dermatologists Share Insights and Experiences
The event also featured insightful academic lectures and discussions on crucial topics, including medical ethics, advertising regulations in aesthetics, and complication management when using Botulinum Toxin. Several esteemed dermatologists honored the event by sharing their expertise:
- Prof. Rungsima Wanitphakdeedecha, M.D., Ph.D. presented on "Toxin Talk: The Do’s & Don’ts for inbo." offering practical advice and precautions for Botulinum Toxin use from the perspectives of both medical practitioners and aesthetic clinics, emphasizing academic accuracy and medical ethics.
- Prof. Vasanop Vachiramon, M.D. provided in-depth insights into raw materials and the variability of different substances in "Understanding the Variability of Botulinum Toxin."
- Asst.Prof. Mart Maiprasert, M.D. lectured on "Boundaries in Medical Advertising: Ethics & Laws," focusing on helping doctors and aesthetic clinics understand the legal framework related to communicating about products like Botulinum Toxin to avoid exaggerated claims.
- Asst. Prof. Dr. Thanya Techapichetvanich, M.D. presented "Injecting with Intention," delving into anatomical perspectives for safe and precise Botulinum Toxin injections.
- Lattaphon Malaithong, M.D. shared knowledge on potential complications from Botulinum Toxin use, covering mechanisms of occurrence, diagnosis, prevention, and appropriate management in "Complications of Botulinum Toxin."
- Chatchai Choosaeng, M.D. explained the technology behind inBo under the topic "Purity, Precision, Performance."
- Kriangkrai Aowudompan, M.D. explained the technology behind TESS PREDERM™ thread lift products, an innovation that enhances deep skin rejuvenation, suitable for use in conjunction with aesthetic procedures like Botulinum Toxin or dermal fillers for smoother and more natural results.
More Than Just a Product Launch - A New Standard in Aesthetics
The development of inBo focuses on the purity of the substance, stable proteins, and the absence of unnecessary complexing proteins, which can potentially reduce the risk of long-term "Botulinum toxin resistance."
For Edencolors, the launch of inBo is not merely about introducing a new product to the market. It also signifies a commitment to elevating Thailand's aesthetic industry to a transparent, verifiable standard, prioritizing consumer safety above all else.
Looking Ahead: Innovation with Responsibility
With the collaboration between Edencolors (Thailand) and Inibio, Korea, inBo is expected to be a new choice for both physicians and consumers seeking a Botulinum Toxin backed by research, and delivers natural-looking results in line with modern aesthetic preferences to enhance their self-confidence.
Edencolors also emphasizes the importance of choosing certified products and undergoing procedures only at licensed and traceable clinics. Edencolors is the sole importer and distributor of inBo in Thailand, and consumers are encouraged to verify product authenticity before receiving treatments to ensure their safety.
For more information about inBo and other Edencolors products, please visit www.edencolors.co.th.
